drugset / Trial / NCT04604600

Multimodal Biomarkers for Diagnosis and Prognosis in VCI

NCT04604600

Phase 3 Unknown 120 enrolled National Taiwan University Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

We will try to 1. establish the correlation of plasma Aβ40 and Aβ42 level, ApoE genotype, MRI imaging markers in the diagnosis and prognosis of VCI patients 2. understand more on the pathophysiology of VCI.

Timeline

Start
2020-09-03
Primary completion
2023-07-31
Completion
2023-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 11C-PiB Diagnostic / imaging agent 10 unknown